![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Initiating long-acting cabotegravir and rilpivirine in a real-world setting: clinical
characteristics and switch reasons from PLHIV and health care provider
perspective in the German CARLOS cohort
|
|
|
AIDS 2022 July 29-Aug 1 Montreal
Christoph Wyen,1 Jenny Scherzer,2 Celia Jonsson-Oldenbuttel,3 Christian Lieb,4 Kevin Ummard-Berger,5 Christiane Cordes,6 Nils Postel,7
Samia Dakhia,8 Bernd Westermayer,9 Katharina Bernhardt2
1Praxis Ebertplatz, Cologne, Germany; 2ViiV Healthcare, Munich, Germany; 3MVZ München am Goetheplatz, Munich, Germany; 4Praxis Goldstein, Berlin, Germany; 5UBN / Praxis, Berlin, Germany;
6Praxis Dr. Cordes, Berlin, Germany ; 7prinzmed, Munich, Germany; 8ViiV Healthcare, Brentford, London UK; 9GlaxoSmithKline, Munich, Germany
![0805221copy](../images/080622/080622-4/0805221copy.gif)
![0805222copy](../images/080622/080622-4/0805222copy.gif)
![0805223copy](../images/080622/080622-4/0805223copy.gif)
![0805224copy](../images/080622/080622-4/0805224copy.gif)
![0805225copy](../images/080622/080622-4/0805225copy.gif)
![0805226copy](../images/080622/080622-4/0805226copy.gif)
![0805227copy](../images/080622/080622-4/0805227copy.gif)
![0805228copy](../images/080622/080622-4/0805228copy.gif)
![0805229copy](../images/080622/080622-4/0805229copy.gif)
![08052210copy](../images/080622/080622-4/08052210copy.gif)
![08052211copy](../images/080622/080622-4/08052211copy.gif)
![08052212copy](../images/080622/080622-4/08052212copy.gif)
![08052213copy](../images/080622/080622-4/08052213copy.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|